Developer:
1268829636
Apple iOS Developer
Med Learning Group
Matched Developer ID: 1268829636
App Count: 40
Developer URL: apps.apple.com/us/developer/-/id1268829636
All apps from developer ID: Med Learning Group
Managing Atopic Dermatitis
Med Learning Group
IRAE-AR
Med Learning Group
Anti-VEGF Advances in Retina
Med Learning Group
CV Augmented Reality
Med Learning Group
DR & PRP Therapy
Med Learning Group
Multiple Myeloma Management
Med Learning Group
Non-Small-Cell Lung Cancer
Med Learning Group
Understanding RVO
Med Learning Group
Shaping the Future of NMSC
Med Learning Group
Medical Management of Melanoma
Med Learning Group
| App | Ratings | Rating | |
|---|---|---|---|
| 1 | Managing Atopic Dermatitis | 0 | - |
| 2 | IRAE-AR | 0 | - |
| 3 | Anti-VEGF Advances in Retina | 0 | - |
| 4 | CV Augmented Reality | 4.00 | 3.0 ⭐ |
| 5 | DR & PRP Therapy | 0 | - |
| 6 | Multiple Myeloma Management | 0 | - |
| 7 | Non-Small-Cell Lung Cancer | 0 | - |
| 8 | Understanding RVO | 1.00 | 5.0 ⭐ |
| 9 | Shaping the Future of NMSC | 0 | - |
| 10 | Medical Management of Melanoma | 0 | - |
Apps Matched by Domain (Possibly Related)
There are 57 apps that are possibly related via the developer's domain (medlearninggroup.com). These may be developer apps on other App Stores or App Store Developers. For social networks like FB/TikTok/X there may be unrelated apps using their social pages as their official domain.
Familial Hypercholesterolemia
MedLearning2017
Treating SR-cGVHD
MedLearning2017
Understanding Rett Syndrome
MedLearning2017
AMD & Anti-VEGF Therapy
MedLearning2017
Targeted Asthma Therapy
MedLearning2017
Targeting Type 2 Inflammation
MedLearning2017
SGLT2 & GLP-1 in Diabetes
MedLearning2017
Myeloma BsAb iAR
MedLearning2017
Anti-VEGF Advances in Retina
MedLearning2017
Moderate to Severe Asthma AR
MedLearning2017
| App | Installs | Rating | |
|---|---|---|---|
| 1 | Familial Hypercholesterolemia | 18 | - |
| 2 | Treating SR-cGVHD | 6.00 | - |
| 3 | Understanding Rett Syndrome | 18 | - |
| 4 | AMD & Anti-VEGF Therapy | 41 | - |
| 5 | Targeted Asthma Therapy | 18 | - |
| 6 | Targeting Type 2 Inflammation | 5.00 | - |
| 7 | SGLT2 & GLP-1 in Diabetes | 54 | - |
| 8 | Myeloma BsAb iAR | 5.00 | - |
| 9 | Anti-VEGF Advances in Retina | 7.00 | - |
| 10 | Moderate to Severe Asthma AR | 119 | - |
Anti-VEGF’s in DR, AMD & RVO
Med Learning Group
Myeloma BsAb iAR
Med Learning Group
Anti-VEGF Advances in Retina
Med Learning Group
Multiple Myeloma Management
Med Learning Group
Managing Atopic Dermatitis
Med Learning Group
Individualizing Diabetes Care
Med Learning Group
Biologics in CRSwNP
Med Learning Group
Covid Frontline AR
Med Learning Group
Medical Management of Melanoma
Med Learning Group
Antiarrhythmics for Afib
Med Learning Group